FDA issued a Warning Letter to Hospira Inc on 2/14/2017 for a previous inspection.
483 Hospira A Pfizer Company Jan 2020

483 Hospira A Pfizer Company Jan 2020

$119 - Not in Stock

FDA investigators audited the Hospira A Pfizer Company - Mcpherson, KS, United States facility and issued inspectional observations (via FDA 483) on 17 Jan 2020.

Product details

  • Category: Human Drugs
  • Inspection end: 17 Jan 2020
  • Location: Mcpherson, United States
  • FEI: 1925262
Order